{
	"annotation": {
		"aeid": 2,
		"assayComponentEndpointName": "ACEA_ER_80hr",
		"assayComponentEndpointDesc": "Data from the assay component ACEA_ER_80hr was analyzed into 2 assay endpoints. This assay endpoint, ACEA_ER_80hr_Positive, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of growth reporter, measures of the cells for gain - of -signal activity can be used to understand the signaling at the pathway - level as they relate to the gene ESR1.",
		"assayFunctionType": "signaling",
		"normalizedDataType": "percent_activity",
		"analysisDirection": "positive",
		"burstAssay": "-",
		"keyPositiveControl": "17b-estradiol",
		"signalDirection": "gain",
		"intendedTargetType": "pathway",
		"intendedTargetTypeSub": "pathway-specified",
		"intendedTargetFamily": "nuclear receptor",
		"intendedTargetFamilySub": "steroidal",
		"assayComponentName": "ACEA_ER_80hr",
		"assayComponentDesc": "ACEA_ER_80hr, is one of two assay component(s) measured or calculated from the ACEA_ER assay. It is designed to make measurements of real-time cell-growth kinetics, a form of growth reporter, as detected with electrical impedance signals by Real-Time Cell Electrode Sensor (RT-CES) technology.",
		"assayComponentTargetDesc": "Electrical impedance is used to quantify changes to the growth of the cells where increase impedance is positively correlated with increased cell growth",
		"parameterReadoutType": "single",
		"assayDesignType": "growth reporter",
		"assayDesignTypeSub": "real-time cell-growth kinetics",
		"biologicalProcessTarget": "cell proliferation",
		"detectionTechnologyType": "Label Free Technology",
		"detectionTechnologyTypeSub": "Electrical Sensor: Impedance",
		"detectionTechnology": "RT-CES",
		"signalDirectionType": "both",
		"keyAssayReagentType": "NA",
		"keyAssayReagent": "NA",
		"technologicalTargetType": "cellular",
		"technologicalTargetTypeSub": "cellular",
		"assayName": "ACEA_ER",
		"assayDesc": "ACEA_ER is a cell-based, single-readout assay that uses T47D, a human breast cell line, with measurements taken at 80 hours after chemical dosing in a 96-well or 384-well plate.",
		"timepointHr": "80",
		"organism": "human",
		"tissue": "breast",
		"cellFormat": "cell line",
		"cellFreeComponentSource": "NA",
		"cellShortName": "T47D",
		"cellGrowthMode": "adherent",
		"assayFootprint": "microplate: 384-well plate",
		"assayFormatType": "cell-based",
		"assayFormatTypeSub": "cell-based format",
		"contentReadoutType": "single",
		"dilutionSolvent": "DMSO",
		"dilutionSolventPercentMax": "0.5",
		"assaySourceName": "ACEA",
		"assaySourceDesc": "ACEA Biosciences, Inc. (ACEA) is a privately owned biotechnology company that developed a real-time, label-free, cell-based assay system based on a microelectronic readout called xCELLigence.",
		"entrezGeneId": "2099",
		"geneName": "estrogen receptor 1",
		"geneSymbol": "ESR1"
	},
	"citations": [
		{
			"pmid": 16481145,
			"author": "Xing JZ, Zhu L, Gabos S, Xie L",
			"title": "Microelectronic cell sensor assay for detection of cytotoxicity and prediction of acute toxicity",
			"citation": "Xing JZ, Zhu L, Gabos S, Xie L. Microelectronic cell sensor assay for detection of cytotoxicity and prediction of acute toxicity. Toxicol In Vitro. 2006 Sep;20(6):995-1004. Epub 2006 Feb 14. PubMed PMID: 16481145.",
			"doi": null,
			"otherId": "0",
			"otherSource": null,
			"url": "http://www.ncbi.nlm.nih.gov/pubmed/16481145"
		},
		{
			"pmid": 23682706,
			"author": "Rotroff DM, Dix DJ, Houck KA, Kavlock RJ, Knudsen TB, Martin MT, Reif DM, Richard AM, Sipes NS, Abassi YA, Jin C, Stampfl M, Judson RS",
			"title": "Real-time growth kinetics measuring hormone mimicry for ToxCast chemicals in T-47D human ductal carcinoma cells",
			"citation": "Rotroff DM, Dix DJ, Houck KA, Kavlock RJ, Knudsen TB, Martin MT, Reif DM, Richard AM, Sipes NS, Abassi YA, Jin C, Stampfl M, Judson RS. Real-time growth kinetics measuring hormone mimicry for ToxCast chemicals in T-47D human ductal carcinoma cells. Chem Res Toxicol. 2013 Jul 15;26(7):1097-107. doi:10.1021/tx400117y. Epub 2013 Jun 10. PubMed PMID: 23682706.",
			"doi": "doi: 10.1021/tx400117y",
			"otherId": "0",
			"otherSource": null,
			"url": "http://www.ncbi.nlm.nih.gov/pubmed/23682706"
		}
	],
	"tcplProcessing": [
		{
			"assayRunType": "multi",
			"levelApplied": 2,
			"methodName": "none",
			"description": "Apply no level 2 method"
		},
		{
			"assayRunType": "multi",
			"levelApplied": 3,
			"methodName": "pval.apid.medpcbyconc.max",
			"description": "plate-wise median response of positive control (max)"
		}
	],
	"reagents": [
		{
			"reagentType": "media_base",
			"reagentValue": "RPMI-1640",
			"cultureOrAssay": "culture"
		},
		{
			"reagentType": "media_base",
			"reagentValue": "10% FBS",
			"cultureOrAssay": "culture"
		}
	],
	"aops": [
		{
			"aopId": 200,
			"aopTitle": "Estrogen receptor activation leading to breast cancer"
		}
	],
	"createdDate": "2016-08-23T17:35:22",
	"lastModifiedDate": "2016-08-23T17:35:22"
}